About Suraksha Diagnostic Ltd IPO

Suraksha Diagnostic Ltd is preparing to launch a Rs 846.25 crore book. It will consist entirely of an offer-for-sale of 1.92 crore shares. The firm is preparing to make its debut on both the BSE and NSE.

Retail investors need to invest a minimum of Rs 14,994. Small NII investors need to invest at least Rs 209,916 for 476 shares, equivalent to 14 lots. Large NII investors need a minimum investment of Rs 1,004,598 for 2,278 shares, which is 67 lots.

Kfin Technologies Ltd is handling registrar duties for this issue. ICICI Securities Ltd, Nuvama Wealth Management Ltd and SBI Capital Markets Ltd are the book running lead managers in this IPO.

Suraksha Diagnostic Ltd IPO GMP Details:

The most recent GMP of the IPO is Rs 0, as of 28th November, 2024 09:24 AM. The IPO has a price band of Rs 441. The estimated listing price for Suraksha Diagnostic Ltd is Rs 441, reflecting a potential gain of 0% per share.

Suraksha Diagnostic Ltd IPO Details

Suraksha Diagnostic Ltd IPO Opening Date and Closing Date	29th November to 3rd December
Face Value	Rs 2 per share
Price Band	Rs 420 to Rs 441 per share
Lot Size	34 Shares
Total Issue Size	19,189,330 shares (aggregating up to Rs 846.25 Cr)
Offer for Sale	19,189,330 shares (aggregating up to Rs 846.25 Cr)
Issue Type	Book-Built Type Issue
Listing At	NSE, BSE
Shareholding Pre-Issue	52,080,758
Basis of Allotment	Wednesday, 4th December, 2024
Refund Initiation	Thursday, 5th December, 2024
Credit of Shares in Demat	Thursday, 5th December, 2024
Listing Date	Friday, 6th December, 2024
Cut-off time for UPI mandate confirmation	5 PM on 3rd December, 2024
Draft Red Herring Prospectus	Link
Red Herring Prospectus	Link

Suraksha Diagnostic Ltd Company Insights

Founded in 2005, Suraksha Diagnostic Limited provides pathology, radiology, and medical consultancy services with a central lab, 8 satellite labs, and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres across West Bengal, Bihar, Assam, and Meghalaya as of 30th June, 2024.

The company provides online and offline medical consultations through 44 diagnostic centres, hosting 120 polyclinics with over 750 doctors.

Its diagnostic centres use advanced systems like LIMS, RIS, PACS, and ERP to streamline operations.

The company offers vaccination services and customized testing for early disease detection.

It uses digital pathology and AI for blood tests, while radiology reports are handled digitally to reduce turnaround time.

Suraksha Diagnostic Ltd IPO Lot Size, Shares, And Their Value:

Application	Lots	Shares	Amount
Retail (Min)	1	34	Rs 14,994
Retail (Max)	13	442	Rs 194,922
S-HNI (Min)	14	476	Rs 209,916
S-HNI (Max)	66	2,244	Rs 989,604
B-HNI (Min)	67	2,278	Rs 1,004,598

Investor categories and Suraksha Diagnostic Ltd shares offered:

Investor Category	Shares Offered
QIB Shares Offered	Not more than 50.00% of the offer
Retail Shares Offered	Not less than 35.00% of the Offer
NII (HNI) Shares Offered	Not less than 15.00% of the Offer

Suraksha Diagnostic Ltd Company Performance:

For the period ended on 31st March, 2024 & 31st March, 2023:

Periods Ended	31st Mar, 2024	31st Mar, 2023
Assets	Rs 300.21 Cr.	Rs 281.20 Cr.
Revenue	Rs 222.26 Cr.	Rs 193.69 Cr.
Profit After Tax	Rs 23.13 Cr.	Rs 6.07 Cr.
Net Worth	Rs 179.41 Cr.	Rs 155.93 Cr.
Reserves and Supplies	Rs 170.88 Cr.	Rs 147.40 Cr.
Total Borrowing	Rs 8.64 Cr.	Rs 14.01 Cr.

Suraksha Diagnostic Ltd IPO: Worth Investing?

Financial Performance:

Revenue: The company generated Rs 61.85 crore in revenue during the period ended on 30th June, 2024.

Profit After Tax (PAT): The company earned a profit of Rs 7.67 crore after deducting taxes.

Net Worth: The company’s net worth, which represents the total value of the company’s assets minus its liabilities, is Rs 187.05 crore.

Financial Position:

Assets: The company’s total assets amounted to Rs 314.20 crore.

Reserves and Surplus: The company has accumulated reserves and surplus of Rs 176.80 crore.

Total Borrowing: The company has borrowed a total of Rs 7.57 crore.

Suraksha Diagnostic Ltd Key Performance Indicators (KPI) and their values:

The market capitalisation of Suraksha Diagnostic Ltd IPO is Rs 2,293.2 crore. As of 31st March, KPI and their values are:

KPI	Values
Return on Equity (ROE)	14.09%
Return on Capital Employed (ROCE)	21.46%
Return on Net Worth (RoNW)	14.09%
Price to Book Value (P/BV)	13.1
Debt/Equity	0.2
PAT Margin (%)	10.57

Objectives of Suraksha Diagnostic Ltd IPO

The company won’t get any funds from the Offer for Sale; all proceeds will go to the selling shareholders.

Some major risks associated with the Suraksha Diagnostic Ltd IPO are:

• Dependence on key regions as the company’s operations are mostly in eastern India, limiting diversification.

• Regulatory compliance in healthcare requires adapting to changing norms, raising operational costs.

• High competition in the diagnostics market from both organized players and local unorganized labs.

• Economic sensitivity affects revenue due to changes in the economy and healthcare spending.

Frequently Asked Questions (FAQs)

What is the price band of Suraksha Diagnostic Ltd IPO?

Price band has been fixed at Rs 420 and Rs 441 per share.

What is the retail investor quota of Suraksha Diagnostic Ltd IPO? 

A minimum of 35% shares shall go to the retail investors.

What is the lot size and share distribution for High Net-Worth Individuals (HNIs)?

The lot size for HNIs is 14 lots, with a total of 476 shares allocated.

How can I apply for Suraksha Diagnostic Ltd Initial Public Offer?

You can apply through your demat account, banking channels, or other financial institutions during the IPO period.

When is the Last Date of IPO subscription for Suraksha Diagnostic Ltd?

The cut-off time is 3rd December, 2024, at 5 PM; however, most brokers stop accepting applications between 1-3 PM.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!